Product Categories
| Country: | China |
|---|---|
| Tel: | 177-54423994 |
| Mobile: | 17754423994 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 2-Methylhexan-2-yl methacrylate | C11H20O2 | 1004549-78-3 | Details |
| ML 145 | C24H22N2O5S2 | 1164500-72-4 | Details |
| AMP-945 | C28H32F3N5O2 | 1393653-34-3 | Details |
| Pactimibe (sulfate) | C25H42N2O7S | 608510-47-0 | Details |
| Doxazosin Impurity C | C22H22N2O6 | 617677-53-9 | Details |
| Buspirone EP Impurity C | C20H30N8 | 257877-45-5 | Details |
| 2-(Acetylamino)-5-chlorobenzenesulfonate Pyridine | C8H8ClNO4S | 54981-41-8 | Details |
| Poloxin | C18H19NO3 | 321688-88-4 | Details |
| CTB | C16H13ClF3NO2 | 451491-47-7 | Details |
| NL-1 | C18H25NO3S | 188532-26-5 | Details |
| 1-Piperazinecarboxylic acid, 4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-5-yl]-, 1,1-dimethylethyl ester | C22H28N4O5 | 2222120-27-4 | Details |
| SSD114 | C18H20F3N3O | 554428-55-6 | Details |
| Methyl 10,11-dihydro-5H-dibenzo[b,f]azepine-4-carboxylate | C16H15NO2 | 22965-12-4 | Details |
| 3-Pyridinecarboxamide, 1,4-dihydro-1-methyl-N-(5-nitro-1,2-benzisothiazol-3-yl)-4-oxo- | C14H10N4O4S | 1821309-39-0 | Details |
| 5,6-Dibromo-2,3-dimethylpyridine | C7H7Br2N | 117846-56-7 | Details |
| Tert-butyl [2-(4-amino-1H-pyrazol-1-yl)ethyl]carbamate oxalate | C12H20N4O6 | 1965304-61-3 | Details |
| CCG-100602 | C21H17ClF6N2O2 | 1207113-88-9 | Details |
| SP-8356 | C18H20O4 | 1454885-45-0 | Details |
| tert-butyl 4-(4-((2,6-dioxopiperidin-3-yl)amino)phenyl)piperidine-1-carboxylate | C21H29N3O4 | 2259851-32-4 | Details |
| GSK3685032 | C22H24N6OS | 2170137-61-6 | Details |
| TSHR antagonist S37 | C25H20N2O3S2 | 1217616-61-9 | Details |
| (2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)phenyl)methanamine | C9H10FN5O | 1821248-00-3 | Details |
| NE10790 | C8H10NO6P | 152831-36-2 | Details |
| PBD dimer | C42H39N5O7 | 1222490-34-7 | Details |
| Phentolamine Analogue 1 | C17H19N3O | 47142-51-8 | Details |
| TY-52156 | C18H19Cl2N3O | 934369-14-9 | Details |
| 6-Cyclopropyl-1-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid | C13H15N3O2 | 851288-57-8 | Details |
| Ebastine Impurity G | C32H39NO3 | 1429071-65-7 | Details |
| Budesonide Impurity 7 | C23H28O7 | 3949-79-9 | Details |
| UNC6934 | C24H21N5O4 | 2561494-77-5 | Details |
| Ebastine Impurity F | C32H39NO3 | 1429071-63-5 | Details |
| Daunomycinone | C21H18O8 | 21794-55-8 | Details |
| BMS-986176 | C19H23F4N3O | 1815613-42-3 | Details |
| FIDAS-3 | C16H15F2N | 1266684-01-8 | Details |
| CR8, (R)-Isomer | C24H29N7O | 294646-77-8 | Details |
| 2-(4-Bromo-2,6-dimethylphenyl)acetonitrile | C10H10BrN | 205035-09-2 | Details |
| Mal-PEG2-CH2COOH | C10H13NO6 | 173323-23-4 | Details |
| B022 | C19H16ClN5OS | 1202764-53-1 | Details |
| Anrukinzumab | 910649-32-0 | Details |
| PROTAC BRD4 ligand-1 | C23H18F2N4O5S | 2313230-51-0 | Details |
| 3X FLAG Peptide | C120H169N31O49S | 402750-12-3 | Details |
| RR6 | C16H23NO4 | 1351758-37-6 | Details |
| GNE-6776 | C20H20N4O2 | 2009273-71-4 | Details |
| L-Phenylalanine, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-, 1,1-dimethylethyl ester | C27H36N4O7 | 1599440-14-8 | Details |
| Dacetuzumab | 880486-59-9 | Details |
| Alacizumab | 934216-54-3 | Details |
| Heptamidine dimethanesulfonate | C22H32N4O5S | 161374-55-6 | Details |
| Etaracizumab | 892553-42-3 | Details |
| LY255283 | C19H28N4O3 | 117690-79-6 | Details |
| GSK-114 | C19H23N5O4S | 1301761-96-5 | Details |
| DGKα inhibitor CU-3 | C16H12N2O4S3 | 1815598-71-0 | Details |
| SHP389 | C23H29ClN8O2 | 2235394-90-6 | Details |
| IXA4 | C24H28N4O4 | 1185329-96-7 | Details |
| Upadacitinib hemihydrate | C17H21F3N6O2 | 2050057-56-0 | Details |
| Lipoxamycin hemisulfate | C19H38N2O9S | 11075-87-9 | Details |
| eIF4A3-IN-1 | C29H23BrClN5O2 | 2095486-67-0 | Details |
| Simufilam dihydrochloride | C15H22ClN3O | 2480226-06-8 | Details |
| Tivozanib hydrochloride hydrate | C22H22Cl2N4O6 | 682745-41-1 | Details |
| 1-Piperidineacetic acid, 4-[4-[(2,6-dioxo-3-piperidinyl)amino]phenyl]-, 1,1-dimethylethyl ester | C22H31N3O4 | 2641512-32-3 | Details |
| (R)-CR8 trihydrochloride | C24H30ClN7O | 1786438-30-9 | Details |
| SJ-172550 | C22H21ClN2O5 | 431979-47-4 | Details |
| Ibalizumab | 680188-33-4 | Details |
| Otelixizumab | 881191-44-2 | Details |
| Tigatuzumab | 918127-53-4 | Details |
| Panobacumab | 885053-97-4 | Details |
| NVR-3-778 | C18H16F4N2O4S | 1445790-55-5 | Details |
| I-BET567 | C17H18ClN5O2 | 1887237-54-8 | Details |
| Pagibaximab | 595566-61-3 | Details |
| Sontuzumab | 372075-37-1 | Details |
| Iratumumab | 640735-09-7 | Details |
| Disitamab Vedotin | 2136633-23-1 | Details |
| Libivirumab | 569658-79-3 | Details |
| SIS3 | C28H27N3O3 | 1009104-85-1 | Details |
| YH53 | C30H33N5O5S | 1471484-62-4 | Details |
| GSK 2033 | C29H28F3NO5S2 | 1221277-90-2 | Details |
| RGD Trifluoroacetate | C14H23F3N6O8 | 2378808-45-6 | Details |
| EIT hydrobromide | C3H9BrN2S | 1071-37-0 | Details |
| BVT948 | C14H11NO3 | 39674-97-0 | Details |
| HLY78 | C17H17NO2 | 854847-61-3 | Details |
| Yttrium (90Y) Tacatuzumab Tetraxetan | 476413-07-7 | Details |
| Rilotumumab | 872514-65-3 | Details |
| Bapineuzumab | 648895-38-9 | Details |
| Tefibazumab | 521079-87-8 | Details |
| Raxibacumab | 565451-13-0 | Details |
| Methyl (2S)-3-(5-bromopyridin-2-yl)-2-[(2-methylpropan-2- yl)oxycarbonylamino]-propanoate | C14H19BrN2O4 | 656801-27-3 | Details |
| (S)-3-Phenylcyclohexanone | C12H14O | 57344-86-2 | Details |
| (R)-Methyl 3-(5-bromopyridin-2-YL)-2-(boc-amino)propanoate | C14H19BrN2O4 | 1391465-94-3 | Details |
| KL-11743 | C30H30N6O3 | 1369452-53-8 | Details |
| 1379676-56-8 | C26H23FN4O4 | 1379676-56-8 | Details |
| Apixaban Impurity 38 | C10H16Cl2O3 | 1802522-36-6 | Details |
| 4-[2-(2,6-dioxo-3-piperidinyl)-6-fluoro-2,3-dihydro-1,3-dioxo-1Hisoindol-5-yl]-, 1,1-dimethylethyl ester-1-Piperazinecarboxylic acid | C22H25FN4O6 | 2222116-02-9 | Details |
| FLT3-IN-3 | C27H38N8O | 2229050-90-0 | Details |
| Exbivirumab | 569658-80-6 | Details |
| Volociximab | 558480-40-3 | Details |
| 7-O-(Triethylsilyl) Baccatin III | C37H52O11Si | 115437-21-3 | Details |
| TBI-166 | C32H30F3N5O3 | 1353734-12-9 | Details |
| WAY-181187 hydrochloride | C15H14Cl2N4O2S2 | 554403-08-6 | Details |
| Besilesomab | 537694-98-7 | Details |
| Edrecolomab | 156586-89-9 | Details |
| (R)-3-Phenylcyclohexanone | C12H14O | 34993-51-6 | Details |
| Product Total： Product Page： | ||||
| 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 | ||||